AKBA FY 2015 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$96,000

Operating Income

-$62M

Net Income

-$61M

EPS (Diluted)

$-2.29

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$53M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$143M

Total Liabilities

$12M

Stockholders' Equity

$131M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$96,000	-$23M	+99.6%
Operating Income	-$62M	-$38M	-62.1%
Net Income	-$61M	-$37M	-63.9%